XELIRI和TEGAFIRI联合贝伐单抗对复发或转移性结直肠癌有效

Clinics of oncology Pub Date : 2020-01-01 DOI:10.47829/coo.2020.3101

Hsu Tc, Liao Pn

{"title":"XELIRI和TEGAFIRI联合贝伐单抗对复发或转移性结直肠癌有效","authors":"Hsu Tc, Liao Pn","doi":"10.47829/coo.2020.3101","DOIUrl":null,"url":null,"abstract":"Both XELIRI And TEGAFIRI Together with Bevacizumab are Effective for Recurrent or Metastatic Colorectal Cancer: A Real-Life Experience Hsu TC and Liao PN Department of Surgery, Division of Colon & Rectal Surgery, Taipei Mackay Memorial Hospital, Taipei, Taiwan ; Department of Medicine, Mackay Medical College, New Taipei City, Taiwan Department of physician, Taipei Mackay Memorial Hospital, Taipei, Taiwan","PeriodicalId":92766,"journal":{"name":"Clinics of oncology","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Both XELIRI And TEGAFIRI Togetherwith Bevacizumab are Effective for Recurrent or Metastatic Colorectal Cancer: A Real-Life Experience\",\"authors\":\"Hsu Tc, Liao Pn\",\"doi\":\"10.47829/coo.2020.3101\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Both XELIRI And TEGAFIRI Together with Bevacizumab are Effective for Recurrent or Metastatic Colorectal Cancer: A Real-Life Experience Hsu TC and Liao PN Department of Surgery, Division of Colon & Rectal Surgery, Taipei Mackay Memorial Hospital, Taipei, Taiwan ; Department of Medicine, Mackay Medical College, New Taipei City, Taiwan Department of physician, Taipei Mackay Memorial Hospital, Taipei, Taiwan\",\"PeriodicalId\":92766,\"journal\":{\"name\":\"Clinics of oncology\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinics of oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47829/coo.2020.3101\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinics of oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47829/coo.2020.3101","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

XELIRI、TEGAFIRI联合贝伐单抗治疗复发性或转移性结直肠癌的临床研究徐涛，廖pn台北麦凯纪念医院结直肠外科台湾新北市麦凯医学院内科，台北麦凯纪念医院内科，台湾台北

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Both XELIRI And TEGAFIRI Togetherwith Bevacizumab are Effective for Recurrent or Metastatic Colorectal Cancer: A Real-Life Experience

Both XELIRI And TEGAFIRI Together with Bevacizumab are Effective for Recurrent or Metastatic Colorectal Cancer: A Real-Life Experience Hsu TC and Liao PN Department of Surgery, Division of Colon & Rectal Surgery, Taipei Mackay Memorial Hospital, Taipei, Taiwan ; Department of Medicine, Mackay Medical College, New Taipei City, Taiwan Department of physician, Taipei Mackay Memorial Hospital, Taipei, Taiwan

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinics of oncology

自引率

0.00%

发文量